Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity
| Autor: | Segota, Ena, Mekhail, Tarek, Olencki, Thomas, Hutson, Thomas E., Dreicer, Robert, Wacker, Brenda, Osterwalder, Bruno, Elson, Paul, Zhou, Ming, Bukowski, Ronald M. |
|---|---|
| Zdroj: | In Urologic Oncology: Seminars and Original Investigations 2007 25(1):46-52 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect